カテゴリー： Market Monitor Global, 世界, 医療/バイオ

ヒト注射用インフルエンザワクチンの世界市場見通し2023年-2029年

◆英語タイトル：Human Injection Flu Vaccine Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8777 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：76 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Human Injection Flu Vaccine Market 調査レポートは次の情報を含め、グローバルにおけるのヒト注射用インフルエンザワクチン市場規模と予測を収録しています。・世界のヒト注射用インフルエンザワクチン市場：売上、2018年-2023年、2024年-2029年
・世界のヒト注射用インフルエンザワクチン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のヒト注射用インフルエンザワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「3価インフルエンザワクチン」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

ヒト注射用インフルエンザワクチンのグローバル主要企業は、Sanofi、 CSL、 GSK、 Viatris、 AstraZeneca、 Hualan Bio、 Changchun Institute of Biological、 Sinovac、 Jiangsu GDK、 KM Biologicsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、ヒト注射用インフルエンザワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のヒト注射用インフルエンザワクチン市場：タイプ別、2018年-2023年、2024年-2029年
世界のヒト注射用インフルエンザワクチン市場：タイプ別市場シェア、2022年
・3価インフルエンザワクチン、4価インフルエンザワクチン

世界のヒト注射用インフルエンザワクチン市場：用途別、2018年-2023年、2024年-2029年
世界のヒト注射用インフルエンザワクチン市場：用途別市場シェア、2022年
・6ヶ月～3歳、3歳以上

世界のヒト注射用インフルエンザワクチン市場：地域・国別、2018年-2023年、2024年-2029年
世界のヒト注射用インフルエンザワクチン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるヒト注射用インフルエンザワクチンのグローバル売上、2018年-2023年
・主要企業におけるヒト注射用インフルエンザワクチンのグローバル売上シェア、2022年
・主要企業におけるヒト注射用インフルエンザワクチンのグローバル販売量、2018年-2023年
・主要企業におけるヒト注射用インフルエンザワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Sanofi、 CSL、 GSK、 Viatris、 AstraZeneca、 Hualan Bio、 Changchun Institute of Biological、 Sinovac、 Jiangsu GDK、 KM Biologics

*************************************************************

・調査・分析レポートの概要
ヒト注射用インフルエンザワクチン市場の定義
市場セグメント
世界のヒト注射用インフルエンザワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のヒト注射用インフルエンザワクチン市場規模
世界のヒト注射用インフルエンザワクチン市場規模：2022年 VS 2029年
世界のヒト注射用インフルエンザワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのヒト注射用インフルエンザワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のヒト注射用インフルエンザワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：3価インフルエンザワクチン、4価インフルエンザワクチン
ヒト注射用インフルエンザワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：6ヶ月～3歳、3歳以上
ヒト注射用インフルエンザワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別ヒト注射用インフルエンザワクチン市場規模 2022年と2029年
地域別ヒト注射用インフルエンザワクチン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Sanofi、 CSL、 GSK、 Viatris、 AstraZeneca、 Hualan Bio、 Changchun Institute of Biological、 Sinovac、 Jiangsu GDK、 KM Biologics
...

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
This report aims to provide a comprehensive presentation of the global market for Human Injection Flu Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Injection Flu Vaccine. This report contains market size and forecasts of Human Injection Flu Vaccine in global, including the following market information:
Global Human Injection Flu Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Human Injection Flu Vaccine Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Human Injection Flu Vaccine companies in 2022 (%)
The global Human Injection Flu Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Trivalent Influenza Vaccine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Human Injection Flu Vaccine include Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac and Jiangsu GDK, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Injection Flu Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Injection Flu Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Human Injection Flu Vaccine Market Segment Percentages, by Type, 2022 (%)
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Global Human Injection Flu Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Human Injection Flu Vaccine Market Segment Percentages, by Application, 2022 (%)
6 Months to 3 Years
> 3 Years
Global Human Injection Flu Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Human Injection Flu Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Injection Flu Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Human Injection Flu Vaccine revenues share in global market, 2022 (%)
Key companies Human Injection Flu Vaccine sales in global market, 2018-2023 (Estimated), (Units)
Key companies Human Injection Flu Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
Jiangsu GDK
KM Biologics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Injection Flu Vaccine, market overview.
Chapter 2: Global Human Injection Flu Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Human Injection Flu Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Injection Flu Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Human Injection Flu Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Human Injection Flu Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Injection Flu Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Injection Flu Vaccine Overall Market Size
2.1 Global Human Injection Flu Vaccine Market Size: 2022 VS 2029
2.2 Global Human Injection Flu Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Human Injection Flu Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Human Injection Flu Vaccine Players in Global Market
3.2 Top Global Human Injection Flu Vaccine Companies Ranked by Revenue
3.3 Global Human Injection Flu Vaccine Revenue by Companies
3.4 Global Human Injection Flu Vaccine Sales by Companies
3.5 Global Human Injection Flu Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Human Injection Flu Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Human Injection Flu Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Injection Flu Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Human Injection Flu Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Injection Flu Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Human Injection Flu Vaccine Market Size Markets, 2022 & 2029
4.1.2 Trivalent Influenza Vaccine
4.1.3 Quadrivalent Influenza Vaccine
4.2 By Type – Global Human Injection Flu Vaccine Revenue & Forecasts
4.2.1 By Type – Global Human Injection Flu Vaccine Revenue, 2018-2023
4.2.2 By Type – Global Human Injection Flu Vaccine Revenue, 2024-2029
4.2.3 By Type – Global Human Injection Flu Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global Human Injection Flu Vaccine Sales & Forecasts
4.3.1 By Type – Global Human Injection Flu Vaccine Sales, 2018-2023
4.3.2 By Type – Global Human Injection Flu Vaccine Sales, 2024-2029
4.3.3 By Type – Global Human Injection Flu Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global Human Injection Flu Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Human Injection Flu Vaccine Market Size, 2022 & 2029
5.1.2 6 Months to 3 Years
5.1.3 > 3 Years
5.2 By Application – Global Human Injection Flu Vaccine Revenue & Forecasts
5.2.1 By Application – Global Human Injection Flu Vaccine Revenue, 2018-2023
5.2.2 By Application – Global Human Injection Flu Vaccine Revenue, 2024-2029
5.2.3 By Application – Global Human Injection Flu Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global Human Injection Flu Vaccine Sales & Forecasts
5.3.1 By Application – Global Human Injection Flu Vaccine Sales, 2018-2023
5.3.2 By Application – Global Human Injection Flu Vaccine Sales, 2024-2029
5.3.3 By Application – Global Human Injection Flu Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global Human Injection Flu Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Human Injection Flu Vaccine Market Size, 2022 & 2029
6.2 By Region – Global Human Injection Flu Vaccine Revenue & Forecasts
6.2.1 By Region – Global Human Injection Flu Vaccine Revenue, 2018-2023
6.2.2 By Region – Global Human Injection Flu Vaccine Revenue, 2024-2029
6.2.3 By Region – Global Human Injection Flu Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global Human Injection Flu Vaccine Sales & Forecasts
6.3.1 By Region – Global Human Injection Flu Vaccine Sales, 2018-2023
6.3.2 By Region – Global Human Injection Flu Vaccine Sales, 2024-2029
6.3.3 By Region – Global Human Injection Flu Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Human Injection Flu Vaccine Revenue, 2018-2029
6.4.2 By Country – North America Human Injection Flu Vaccine Sales, 2018-2029
6.4.3 US Human Injection Flu Vaccine Market Size, 2018-2029
6.4.4 Canada Human Injection Flu Vaccine Market Size, 2018-2029
6.4.5 Mexico Human Injection Flu Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Human Injection Flu Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe Human Injection Flu Vaccine Sales, 2018-2029
6.5.3 Germany Human Injection Flu Vaccine Market Size, 2018-2029
6.5.4 France Human Injection Flu Vaccine Market Size, 2018-2029
6.5.5 U.K. Human Injection Flu Vaccine Market Size, 2018-2029
6.5.6 Italy Human Injection Flu Vaccine Market Size, 2018-2029
6.5.7 Russia Human Injection Flu Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Human Injection Flu Vaccine Market Size, 2018-2029
6.5.9 Benelux Human Injection Flu Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Human Injection Flu Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia Human Injection Flu Vaccine Sales, 2018-2029
6.6.3 China Human Injection Flu Vaccine Market Size, 2018-2029
6.6.4 Japan Human Injection Flu Vaccine Market Size, 2018-2029
6.6.5 South Korea Human Injection Flu Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Human Injection Flu Vaccine Market Size, 2018-2029
6.6.7 India Human Injection Flu Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Human Injection Flu Vaccine Revenue, 2018-2029
6.7.2 By Country – South America Human Injection Flu Vaccine Sales, 2018-2029
6.7.3 Brazil Human Injection Flu Vaccine Market Size, 2018-2029
6.7.4 Argentina Human Injection Flu Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Human Injection Flu Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Human Injection Flu Vaccine Sales, 2018-2029
6.8.3 Turkey Human Injection Flu Vaccine Market Size, 2018-2029
6.8.4 Israel Human Injection Flu Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Human Injection Flu Vaccine Market Size, 2018-2029
6.8.6 UAE Human Injection Flu Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Human Injection Flu Vaccine Major Product Offerings
7.1.4 Sanofi Human Injection Flu Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 CSL
7.2.1 CSL Company Summary
7.2.2 CSL Business Overview
7.2.3 CSL Human Injection Flu Vaccine Major Product Offerings
7.2.4 CSL Human Injection Flu Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 CSL Key News & Latest Developments
7.3 GSK
7.3.1 GSK Company Summary
7.3.2 GSK Business Overview
7.3.3 GSK Human Injection Flu Vaccine Major Product Offerings
7.3.4 GSK Human Injection Flu Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 GSK Key News & Latest Developments
7.4 Viatris
7.4.1 Viatris Company Summary
7.4.2 Viatris Business Overview
7.4.3 Viatris Human Injection Flu Vaccine Major Product Offerings
7.4.4 Viatris Human Injection Flu Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Viatris Key News & Latest Developments
7.5 AstraZeneca
7.5.1 AstraZeneca Company Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Human Injection Flu Vaccine Major Product Offerings
7.5.4 AstraZeneca Human Injection Flu Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 AstraZeneca Key News & Latest Developments
7.6 Hualan Bio
7.6.1 Hualan Bio Company Summary
7.6.2 Hualan Bio Business Overview
7.6.3 Hualan Bio Human Injection Flu Vaccine Major Product Offerings
7.6.4 Hualan Bio Human Injection Flu Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 Hualan Bio Key News & Latest Developments
7.7 Changchun Institute of Biological
7.7.1 Changchun Institute of Biological Company Summary
7.7.2 Changchun Institute of Biological Business Overview
7.7.3 Changchun Institute of Biological Human Injection Flu Vaccine Major Product Offerings
7.7.4 Changchun Institute of Biological Human Injection Flu Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 Changchun Institute of Biological Key News & Latest Developments
7.8 Sinovac
7.8.1 Sinovac Company Summary
7.8.2 Sinovac Business Overview
7.8.3 Sinovac Human Injection Flu Vaccine Major Product Offerings
7.8.4 Sinovac Human Injection Flu Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 Sinovac Key News & Latest Developments
7.9 Jiangsu GDK
7.9.1 Jiangsu GDK Company Summary
7.9.2 Jiangsu GDK Business Overview
7.9.3 Jiangsu GDK Human Injection Flu Vaccine Major Product Offerings
7.9.4 Jiangsu GDK Human Injection Flu Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 Jiangsu GDK Key News & Latest Developments
7.10 KM Biologics
7.10.1 KM Biologics Company Summary
7.10.2 KM Biologics Business Overview
7.10.3 KM Biologics Human Injection Flu Vaccine Major Product Offerings
7.10.4 KM Biologics Human Injection Flu Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 KM Biologics Key News & Latest Developments
8 Global Human Injection Flu Vaccine Production Capacity, Analysis
8.1 Global Human Injection Flu Vaccine Production Capacity, 2018-2029
8.2 Human Injection Flu Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Injection Flu Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Human Injection Flu Vaccine Supply Chain Analysis
10.1 Human Injection Flu Vaccine Industry Value Chain
10.2 Human Injection Flu Vaccine Upstream Market
10.3 Human Injection Flu Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Injection Flu Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Human Injection Flu Vaccine in Global Market
Table 2. Top Human Injection Flu Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Human Injection Flu Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Human Injection Flu Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Human Injection Flu Vaccine Sales by Companies, (Units), 2018-2023
Table 6. Global Human Injection Flu Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Human Injection Flu Vaccine Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Human Injection Flu Vaccine Product Type
Table 9. List of Global Tier 1 Human Injection Flu Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Injection Flu Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Human Injection Flu Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Human Injection Flu Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Human Injection Flu Vaccine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Human Injection Flu Vaccine Sales (Units), 2018-2023
Table 15. By Type - Global Human Injection Flu Vaccine Sales (Units), 2024-2029
Table 16. By Application – Global Human Injection Flu Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Human Injection Flu Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Human Injection Flu Vaccine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Human Injection Flu Vaccine Sales (Units), 2018-2023
Table 20. By Application - Global Human Injection Flu Vaccine Sales (Units), 2024-2029
Table 21. By Region – Global Human Injection Flu Vaccine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Human Injection Flu Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Human Injection Flu Vaccine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Human Injection Flu Vaccine Sales (Units), 2018-2023
Table 25. By Region - Global Human Injection Flu Vaccine Sales (Units), 2024-2029
Table 26. By Country - North America Human Injection Flu Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Human Injection Flu Vaccine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Human Injection Flu Vaccine Sales, (Units), 2018-2023
Table 29. By Country - North America Human Injection Flu Vaccine Sales, (Units), 2024-2029
Table 30. By Country - Europe Human Injection Flu Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Human Injection Flu Vaccine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Human Injection Flu Vaccine Sales, (Units), 2018-2023
Table 33. By Country - Europe Human Injection Flu Vaccine Sales, (Units), 2024-2029
Table 34. By Region - Asia Human Injection Flu Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Human Injection Flu Vaccine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Human Injection Flu Vaccine Sales, (Units), 2018-2023
Table 37. By Region - Asia Human Injection Flu Vaccine Sales, (Units), 2024-2029
Table 38. By Country - South America Human Injection Flu Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Human Injection Flu Vaccine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Human Injection Flu Vaccine Sales, (Units), 2018-2023
Table 41. By Country - South America Human Injection Flu Vaccine Sales, (Units), 2024-2029
Table 42. By Country - Middle East & Africa Human Injection Flu Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Human Injection Flu Vaccine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Human Injection Flu Vaccine Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa Human Injection Flu Vaccine Sales, (Units), 2024-2029
Table 46. Sanofi Company Summary
Table 47. Sanofi Human Injection Flu Vaccine Product Offerings
Table 48. Sanofi Human Injection Flu Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Sanofi Key News & Latest Developments
Table 50. CSL Company Summary
Table 51. CSL Human Injection Flu Vaccine Product Offerings
Table 52. CSL Human Injection Flu Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. CSL Key News & Latest Developments
Table 54. GSK Company Summary
Table 55. GSK Human Injection Flu Vaccine Product Offerings
Table 56. GSK Human Injection Flu Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. GSK Key News & Latest Developments
Table 58. Viatris Company Summary
Table 59. Viatris Human Injection Flu Vaccine Product Offerings
Table 60. Viatris Human Injection Flu Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Viatris Key News & Latest Developments
Table 62. AstraZeneca Company Summary
Table 63. AstraZeneca Human Injection Flu Vaccine Product Offerings
Table 64. AstraZeneca Human Injection Flu Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. AstraZeneca Key News & Latest Developments
Table 66. Hualan Bio Company Summary
Table 67. Hualan Bio Human Injection Flu Vaccine Product Offerings
Table 68. Hualan Bio Human Injection Flu Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Hualan Bio Key News & Latest Developments
Table 70. Changchun Institute of Biological Company Summary
Table 71. Changchun Institute of Biological Human Injection Flu Vaccine Product Offerings
Table 72. Changchun Institute of Biological Human Injection Flu Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Changchun Institute of Biological Key News & Latest Developments
Table 74. Sinovac Company Summary
Table 75. Sinovac Human Injection Flu Vaccine Product Offerings
Table 76. Sinovac Human Injection Flu Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Sinovac Key News & Latest Developments
Table 78. Jiangsu GDK Company Summary
Table 79. Jiangsu GDK Human Injection Flu Vaccine Product Offerings
Table 80. Jiangsu GDK Human Injection Flu Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Jiangsu GDK Key News & Latest Developments
Table 82. KM Biologics Company Summary
Table 83. KM Biologics Human Injection Flu Vaccine Product Offerings
Table 84. KM Biologics Human Injection Flu Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. KM Biologics Key News & Latest Developments
Table 86. Human Injection Flu Vaccine Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 87. Global Human Injection Flu Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Human Injection Flu Vaccine Production by Region, 2018-2023 (Units)
Table 89. Global Human Injection Flu Vaccine Production by Region, 2024-2029 (Units)
Table 90. Human Injection Flu Vaccine Market Opportunities & Trends in Global Market
Table 91. Human Injection Flu Vaccine Market Drivers in Global Market
Table 92. Human Injection Flu Vaccine Market Restraints in Global Market
Table 93. Human Injection Flu Vaccine Raw Materials
Table 94. Human Injection Flu Vaccine Raw Materials Suppliers in Global Market
Table 95. Typical Human Injection Flu Vaccine Downstream
Table 96. Human Injection Flu Vaccine Downstream Clients in Global Market
Table 97. Human Injection Flu Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Human Injection Flu Vaccine Segment by Type in 2022
Figure 2. Human Injection Flu Vaccine Segment by Application in 2022
Figure 3. Global Human Injection Flu Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Human Injection Flu Vaccine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Human Injection Flu Vaccine Revenue, 2018-2029 (US$, Mn)
Figure 7. Human Injection Flu Vaccine Sales in Global Market: 2018-2029 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Human Injection Flu Vaccine Revenue in 2022
Figure 9. By Type - Global Human Injection Flu Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Human Injection Flu Vaccine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Human Injection Flu Vaccine Sales Market Share, 2018-2029
Figure 12. By Type - Global Human Injection Flu Vaccine Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Human Injection Flu Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Human Injection Flu Vaccine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Human Injection Flu Vaccine Sales Market Share, 2018-2029
Figure 16. By Application - Global Human Injection Flu Vaccine Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Human Injection Flu Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Human Injection Flu Vaccine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Human Injection Flu Vaccine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Human Injection Flu Vaccine Sales Market Share, 2018-2029
Figure 21. By Country - North America Human Injection Flu Vaccine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Human Injection Flu Vaccine Sales Market Share, 2018-2029
Figure 23. US Human Injection Flu Vaccine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Human Injection Flu Vaccine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Human Injection Flu Vaccine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Human Injection Flu Vaccine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Human Injection Flu Vaccine Sales Market Share, 2018-2029
Figure 28. Germany Human Injection Flu Vaccine Revenue, (US$, Mn), 2018-2029
Figure 29. France Human Injection Flu Vaccine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Human Injection Flu Vaccine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Human Injection Flu Vaccine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Human Injection Flu Vaccine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Human Injection Flu Vaccine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Human Injection Flu Vaccine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Human Injection Flu Vaccine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Human Injection Flu Vaccine Sales Market Share, 2018-2029
Figure 37. China Human Injection Flu Vaccine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Human Injection Flu Vaccine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Human Injection Flu Vaccine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Human Injection Flu Vaccine Revenue, (US$, Mn), 2018-2029
Figure 41. India Human Injection Flu Vaccine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Human Injection Flu Vaccine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Human Injection Flu Vaccine Sales Market Share, 2018-2029
Figure 44. Brazil Human Injection Flu Vaccine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Human Injection Flu Vaccine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Human Injection Flu Vaccine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Human Injection Flu Vaccine Sales Market Share, 2018-2029
Figure 48. Turkey Human Injection Flu Vaccine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Human Injection Flu Vaccine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Human Injection Flu Vaccine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Human Injection Flu Vaccine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Human Injection Flu Vaccine Production Capacity (Units), 2018-2029
Figure 53. The Percentage of Production Human Injection Flu Vaccine by Region, 2022 VS 2029
Figure 54. Human Injection Flu Vaccine Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ヒト注射用インフルエンザワクチンの世界市場見通し2023年-2029年(Human Injection Flu Vaccine Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

ヒト注射用インフルエンザワクチンの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp